Literature DB >> 8875941

Quantitative image analysis of HIV-1 infection in lymphoid tissue.

A T Haase1, K Henry, M Zupancic, G Sedgewick, R A Faust, H Melroe, W Cavert, K Gebhard, K Staskus, Z Q Zhang, P J Dailey, H H Balfour, A Erice, A S Perelson.   

Abstract

Tracking human immunodeficiency virus-type 1 (HIV-1) infection at the cellular level in tissue reservoirs provides opportunities to better understand the pathogenesis of infection and to rationally design and monitor therapy. A quantitative technique was developed to determine viral burden in two important cellular compartments in lymphoid tissues. Image analysis and in situ hybridization were combined to show that in the presymptomatic stages of infection there is a large, relatively stable pool of virions on the surfaces of follicular dendritic cells and a smaller pool of productively infected cells. Despite evidence of constraints on HIV-1 replication in the infected cell population in lymphoid tissues, estimates of the numbers of these cells and the virus they could produce are consistent with the quantities of virus that have been detected in the bloodstream. The cellular sources of virus production and storage in lymphoid tissues can now be studied with this approach over the course of infection and treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8875941     DOI: 10.1126/science.274.5289.985

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  199 in total

1.  Immune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytes.

Authors:  J J Jakubik; M Saifuddin; D M Takefman; G T Spear
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  HIV evolutionary genetics.

Authors:  A G Rodrigo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

3.  Linkage disequilibrium test implies a large effective population number for HIV in vivo.

Authors:  I M Rouzine; J M Coffin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

4.  Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA.

Authors:  G P Rizzardi; R J De Boer; S Hoover; G Tambussi; A Chapuis; N Halkic; P A Bart; V Miller; S Staszewski; D W Notermans; L Perrin; C H Fox; J M Lange; A Lazzarin; G Pantaleo
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

5.  Benchmarks for antiretroviral therapy.

Authors:  O J Cohen; A S Fauci
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

6.  Dissociation of HIV-1 from follicular dendritic cells during HAART: mathematical analysis.

Authors:  W S Hlavacek; C Wofsy; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

7.  Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy.

Authors:  N M Ferguson; F deWolf; A C Ghani; C Fraser; C A Donnelly; P Reiss; J M Lange; S A Danner; G P Garnett; J Goudsmit; R M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 8.  Transition between stochastic evolution and deterministic evolution in the presence of selection: general theory and application to virology.

Authors:  I M Rouzine; A Rodrigo; J M Coffin
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

9.  Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

Authors:  K A Staskus; R Sun; G Miller; P Racz; A Jaslowski; C Metroka; H Brett-Smith; A T Haase
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

10.  B lymphocytes in lymph nodes and peripheral blood are important for binding immune complexes containing HIV-1.

Authors:  J J Jakubik; M Saifuddin; D M Takefman; G T Spear
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.